Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion type Assertion NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_head.
- NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion description "[The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_provenance.
- NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion evidence source_evidence_curated NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_provenance.
- NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion SIO_000772 21185263 NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_provenance.
- NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion wasDerivedFrom ctd_human-2016 NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_provenance.
- NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_assertion wasGeneratedBy ECO_0000218 NP27906.RATyy3y2ciHkB7JHVUKy3osEGlEmK8AD7P8-RxfHc7Bjk130_provenance.